Page last updated: 2024-08-23

amikacin and Myocardial Ischemia

amikacin has been researched along with Myocardial Ischemia in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gao, EH; Koch, WJ; Lau, WB; Li, R; Liang, B; Ma, XL; Wang, YJ; Yuan, YX; Zhang, Y; Zhao, J1

Other Studies

1 other study(ies) available for amikacin and Myocardial Ischemia

ArticleYear
AdipoRon, the first orally active adiponectin receptor activator, attenuates postischemic myocardial apoptosis through both AMPK-mediated and AMPK-independent signalings.
    American journal of physiology. Endocrinology and metabolism, 2015, Aug-01, Volume: 309, Issue:3

    Topics: Adiponectin; Administration, Oral; AMP-Activated Protein Kinases; Animals; Apoptosis; Cardiotonic Agents; Heart Ventricles; Hypoglycemic Agents; Male; Mice, Knockout; Mice, Transgenic; Mutant Proteins; Myocardial Ischemia; Myocardial Reperfusion Injury; Oxidative Stress; Piperidines; Random Allocation; Receptors, Adiponectin; Signal Transduction

2015